These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 6885203

  • 1. Pharmacokinetics and pharmacodynamics of a short- and long-acting theophylline medication (Theolair and Theolair retard) in normals and asthmatics. Part II: Lung function and side effects.
    Utama I, Kreukniet J, Fokkens J, Serra R.
    Int J Clin Pharmacol Ther Toxicol; 1983 Jun; 21(6):292-6. PubMed ID: 6885203
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics and pharmacodynamics of a short- and long-acting theophylline medication (Theolair and Theolair retard) in normals and patients with COLD. Part III: Plasma cyclic AMP.
    Kreukniet J, Utama I, Hamelink ML.
    Int J Clin Pharmacol Ther Toxicol; 1983 Jun; 21(6):297-300. PubMed ID: 6309681
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics and pharmacodynamics of a short- and long-acting theophylline medication (theolair and Theolair retard) in normals and asthmatics. Part I: pharmacokinetics.
    Utama I, Kreukniet J, Meering PG, Maes RA.
    Int J Clin Pharmacol Ther Toxicol; 1983 Jun; 21(6):287-91. PubMed ID: 6885202
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (Theograd, 350 mg Theolair Retard, and 300 mg Theolin Retard) in steady state in six normals and six patients with chronic asthmatic bronchitis--Part II: Lung function.
    van der Vet AP, Kreukniet J, Drost RH, Maes RA.
    Int J Clin Pharmacol Ther Toxicol; 1985 Jul; 23(7):339-44. PubMed ID: 4030161
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (350 mg Theograd, 350 mg Theolair Retard and 300 mg Theodur) in steady state in healthy volunteers and asthmatics--Part I: Theophylline plasma levels.
    van der Vet AP, Drost RH, Kreukniet J, Maes RA.
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):423-9. PubMed ID: 6490224
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Role of theophyllines in severe chronic obstructive pulmonary disease.
    McNicholas WT, Mulloy E.
    Postgrad Med J; 1991 Aug; 67 Suppl 4():S30-3. PubMed ID: 1758832
    [Abstract] [Full Text] [Related]

  • 9. [Comparison of two long-acting theophylline preparations in daily evening administration].
    Holzer R.
    Wien Med Wochenschr; 1993 Aug; 143(2):37-42. PubMed ID: 8488685
    [Abstract] [Full Text] [Related]

  • 10. [Therapy of obstructive respiratory tract diseases with pure theophylline retard].
    Arens PJ.
    Med Klin Prax; 1982 Aug 27; 77(18):48-53, 67. PubMed ID: 6752679
    [Abstract] [Full Text] [Related]

  • 11. Pharmacodynamics (lung function tests, tremor measurements and cAMP determinations) of a single dose of 0.5 mg terbutaline subcutaneously during sustained-release theophylline medication in patients with asthmatic bronchitis.
    van der Vet AP, Kreukniet J, Drost RH, Maes RA, Fokkens JK, Hamelink ML.
    Int J Clin Pharmacol Ther Toxicol; 1986 Oct 27; 24(10):569-73. PubMed ID: 3023243
    [Abstract] [Full Text] [Related]

  • 12. [The comparative efficacy of the prolonged-action theophylline preparations Theopek and Euphylong in elderly patients with chronic obstructive lung diseases].
    Salikova VV, Nonikov VE, Belousov IuB.
    Ter Arkh; 1993 Oct 27; 65(8):41-4. PubMed ID: 8211801
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of the effectiveness and safety of a controlled-release theophylline in patients with reversible and stable bronchial obstruction.
    Grassi V, Nicora M, Beretta A.
    Int J Clin Pharmacol Res; 1987 Oct 27; 7(5):337-44. PubMed ID: 3667006
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The effect of protheo on pulmonary function and the change of its plasma concentration in patients with chronic asthmatic bronchitis].
    Li S, Chen Y, Tan P.
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Oct 27; 20(5):299-300. PubMed ID: 10374457
    [Abstract] [Full Text] [Related]

  • 19. [Comparison of 2 theophylline delayed-action preparations of different galenic forms].
    Hirsch H.
    Wien Med Wochenschr; 1983 Aug 31; 133(15-16):403-8. PubMed ID: 6636797
    [Abstract] [Full Text] [Related]

  • 20. Guide to oral theophylline therapy for the treatment of chronic asthma.
    Hendeles L, Weinberger M, Wyatt R.
    Am J Dis Child; 1978 Sep 31; 132(9):876-80. PubMed ID: 685905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.